Reliable Global RLD Sourcing for Clinical Research & Drug Development

Ikris Pharma Network specializes in the global sourcing of Reference Listed Drugs (RLDs) and Comparator products for pharmaceutical research, clinical trials, and generic drug development. With over a decade of expertise, we have become a trusted Global RLD Supplier for leading pharmaceutical companies, CROs, CDMOs, and research institutions worldwide.
 

Whether you are conducting bioequivalence studies, generic development, or clinical research, our tailored RLD sourcing solutions are designed to support your project with compliance, speed, and transparency.

“Pharmacists reviewing reference listed drugs (RLDs) for clinical research and pharmaceutical development.”
“Experts evaluating pharmaceutical products to ensure authentic and compliant RLD sourcing for global clinical trials.”

Key Advantages of Working with Ikris Pharma Network

  • Fully Compliant & Regulated Operations: Our operations in India and Europe are WHO-GDP, EU-GDP, and ISO-certified, ensuring 100% compliance with CDSCO, DGFT, FDA, and EMA regulations. We provide complete documentation and regulatory transparency for every supply.
  • Hard-to-Find RLD & Comparator Sourcing: We specialize in sourcing rare, complex, and high-value medicines such as Lynparza, Nilotinib, Keytruda, Iclusig, Trodelvy, Polivy, and more—ensuring access to even the most challenging molecules.
  • 100% Authentic & Traceable Products: Every Reference Listed Drug supply is sourced directly from licensed manufacturers, Marketing Authorization Holders (MAHs), or their authorized distributors, guaranteeing authenticity, traceability, and regulatory acceptance.
  • Custom Sourcing Solutions: From single-batch requirements to multi-country sourcing, extended shelf-life requests, or custom packaging needs, we adapt to your specific clinical and regulatory requirements.
  • Stringent Quality Control & Cold Chain Logistics: All products undergo rigorous quality checks and are shipped through validated temperature-controlled logistics to preserve integrity. We maintain GDP-compliant warehouses in Belgium, Bulgaria, and India for global distribution.
  • Fast Turnaround & Competitive Pricing: With dedicated account managers and an agile procurement process, we ensure rapid response times, competitive pricing, and reliable delivery schedules worldwide.

Why Choose Ikris Pharma Network?

  • Over 11 years of global pharmaceutical sourcing experience
  • Recognized Global RLD Supplier trusted by innovators and generic developers
  • EU-GDP warehouses in Belgium & Bulgaria for seamless European distribution
  • WHO-GDP, CDSCO, and DGFT compliance for regulatory confidence
  • End-to-end project support for RLD sourcing, comparator sourcing, and patient access programs

Let’s Work Together:

We would be delighted to support your RLD and Comparator sourcing needs and contribute to the success of your clinical research and development projects.

Contact Us:

Belgium Office

Ikris Pharma International Rue Zenobe Gramme 39, 4821 Andrimont, Belgium

Phone: +32 4 286 12 16, +32 4 286 44 70

Thinking About RLDs or Comparators? Think Ikris Pharma Network.
Your trusted partner for Reference Listed Drug supply, Comparator sourcing, and global RLD sourcing solutions.

Location: Belgium

Comments

Post a Comment

Popular posts from this blog

Why India Is Emerging as a Trusted Hub for Pharmaceutical Exporters?

Image
India’s pharmaceutical industry has become the world’s backbone for affordable, high-quality medicines. By volume, India supplies about 20% of global generic drugs, and meets roughly 60% of global vaccine demand—a scale unmatched by most markets. Scale, Momentum, and Market Reach: India’s export engine keeps accelerating. Pharmaceutical exports touched roughly USD 30.47 billion in FY25, up 9.4% year-on-year, signaling healthy global demand despite pricing pressure and regulatory complexity. Indian manufacturers and exporters now supply medicines to 200+ countries, including the most highly regulated markets, reflecting deep distribution networks and regulatory maturity.       Quality Systems Trusted by Stringent Regulators: A core reason buyers trust India is its compliance footprint. India hosts the largest number of US-FDA–compliant pharmaceutical plants outside the United States, alongside facilities aligned to EMA, WHO-GMP, and other global standards. This dense ...
Read more